Académique Documents
Professionnel Documents
Culture Documents
1.1 History
Allergic diseases have been known for centuries, and allergic diseases such as asthma, urticaria and eczema were described in the ancient
medical literature of China, Egypt, and Greece
(Table 1.1) [7, 22, 24]. The first allergic individual in world history might have been the Egyptian pharaoh Menes, who according to the hieroglyphs died in the year 2,641 B.C. after a
wasp sting [1].
The first family history of atopy syndrome
with asthma, rhinoconjunctivitis and atopic eczema can be found in the Julian-Claudian imperial family of Augustus, Claudius, and Britannicus [20] (Fig. 1.1). In the middle ages, rose fever with hay-fever-like symptoms was a wellknown entity. Richard III of England was allergic
against strawberries according to Shakespeare.
Year
Author
Disease
2698 B.C.
2641 B.C.
460 B.C.
25 B.C.
120 180
600
865
1135 1204
1565
1783
1802
1819
1837
1853
1886
1868
1872
1872
Huang Ti
Hieroglyphs
Hippocrates
A. Celsus
Aretaeus of Kapadokia
Aetius of Amida
Rhazes
Moses Maimonides
L. Botallus
Philipp Phoebus
W. Heberden
J. Bostock
J.L. Schoenlein
J.M. Charcot
E. van Leyden
H.H. Salter
H.I. Quincke
Wyman
Noisy breathing
Death by wasp sting (Pharaoh Menes)
Hypersensitivity against goats cheese
Description of asthma
Term asthma
Term eczema
Rose fever in Persia
Treatment of asthma
Rose fever in Pavia
Hay fever (monography)
Summer catarrh
Self-description of hay fever
Purpura rheumatica
Crystals in asthma sputum
Crystals in asthma sputum
Different asthma elicitors
Angioedema
Autumnal catarrh (from ragweed)
Year
Author
Condition
1873
1877
1895
1900
1902
1903
1903
1905
1906
1906
1910
1910
1911
1921
1923
1924
1927
1928
1928
1937
1939
1940
1941
1949
1952
1953
1954
1956
1958
1960
1961
1963
1964
1966
1967
1967
1967
1969
1977
1978
1979
1984
1987
1988
1989
1989
1987
1987
1996
Ch. Blackley
P. Ehrlich
J. Jadassohn
S. Solis-Cohen
Ch. Richet, P. Portier
M. Arthus
Th. Smith
von Pirquet, B. Schick
von Pirquet
A. Wolff-Eisner
W. Dunbar
H. Dale, Laidlaw
L. Noon, J. Freeman
C. Prausnitz, F. Kstner
A. Coca, R. Cooke
K.K. Shen, C.F. Schmidt
Th. Lewis
W. Storm van Leeuwen
H. Kmmerer
Bovet/Staub
H.H. Donally
M. Loveless
K. Hansen
P.L. Hench, E.C. Kendall
Z. Ovary
J.F. Riley, G. West
W. Frankland
W. Gronemeyer, E. Fuchs
F. Dixon
B.B. Levine, A. de Weck
J. Pepys
R.R.A. Coombs, P. Gell
L. Lichtenstein, A. Osler
K. Ishizaka
S.G.O. Johansson
R. Vorhoorst, F. Spieksma
R. Altounyan
E. Macher, R. Chase
B. Halpern
P. Kallos
B. Samuelsson
H. Metzger
T. Mossmann
V. Coffmann
H. Behrendt
D. Kraft, Baldo
K. Mullis
P. Piper
C. Heusser
Allergy
Hypersensitivity
Idiosyncrasy
Toxicity
Intoxication
Intolerance
Sensitization
Pseudo-allergy
Symptomsa
Differential diagnosis
Cardiovascular
Anaphylaxis, vasculitis
Lung
Upper airways
Eye
Ear
Blood
CNS
Fever
Infectious diseases
(Cramps)
Neurological diseases
(Migraine?)
Skin
Oral/genital
mucosa
Urticaria, angioedema
Vasculitis
Non-inflammatory purpura
Drug-induced exanthematous
eruptions
Granulomatous reactions
Musculoskeletal Arthralgia
Kidney
Type Pathophysiology
I
II
III
IV
V
VI
Clinical examples
IgE
Anaphylaxis
Allergic rhinitis
Allergic bronchial asthma
Allergic conjunctivitis
Allergic urticaria
Allergic gastroenteritis
(Atopic eczema?)
Cytotoxic
Hemolytic anemia
Agranulocytosis
Thrombocytopenic purpura
Immune complexes
Serum sickness
Immune complex anaphylaxis
Vasculitis
Hypersensitivity pneumonitis
Nephritis
Arthritis
Cellular hypersensitivity Type IVa (TH1) allergic contact dermatitis
Type IVb (TH2) atopic eczema
Type IVc (CD8) drug-induced exanthematous
eruptions (purpura pigmentosa progressiva)
Bullous drug eruptions
Granulomatous reactions Granulomas after injections (e.g., bovine
collagen)
Stimulating (neutral- Autoimmune thyreoiditis
izing) hypersensitivity Myasthenia gravis
Reverse anaphylaxis
Insulin resistance
Chronic urticaria? (subpopulation with autoantibodies against Fc 5 RI)
Allergies are seen in almost every organ (Table 1.4). Most frequently, however, it is the skin
and the mucous membranes that are involved
and that represent the interface between the individual organism and its environment [1 27].
Type I. This type comprises IgE-mediated reactions (classical immediate-type allergic reactions), allergic rhinoconjunctivitis, allergic
bronchial asthma, urticaria, angioedema, and
anaphylaxis. The pathophysiological principle
is the release of vasoactive mediators after the
bridging of at least two IgE molecules on the
surface of mast cells and basophil leukocytes
by the allergen. This reaction does not need
complement activation. Atopic eczema is characterized by elevated serum IgE levels.
Type II. The not so frequent reactions of type
II (mostly hematologic diseases) develop
through the action of cytotoxic antibodies directed against surface determinants of cells (after a drug, for instance, has been attached as a
hapten to the surface of leukocytes, platelets, or
erythrocytes and leads to allergic agranulocytosis or thrombocytopenia).
Enviroment-induced disease
Toxicity
of a substance
Hypersensitivity of
the individuum
nonimmune
Irritation,
Intoxication,
chronic
damage
In tolerance
Psychoneurogenic
reaction
immunemediated
Idiosyncrasy
Allergy
sitivity (DTH), whereas TH2 reactions are important in the early phase of atopic eczema.
Type V. The recently suggested type V category describes granulomatous reactions (such as
after injection of foreign material) (e.g., zirconium or soluble bovine collagen) after
2 5 weeks characterized histologically by epithelioid cell granulomas.
Type VI. Pathogenic hypersensitivity reactions occurring through the specific antibody
action have been called stimulating/neutralizing hypersensitivity (I. Roitt) and occur in autoimmune diseases such as thyreoiditis (LATS,
long-acting thyroid-stimulating factor) or myasthenia gravis with antibodies against the acetylcholine receptor in the motoneuron. Socalled reverse anaphylaxis after injection of
antibodies (e.g., anti-IgE or antibodies against
the IgE receptor) might also be mentioned
here; there is some overlap with type II reactions.
Generally, it should be stressed that every
classification is predominantly of a didactic nature. In the living organism unlike in a textbook different types of reactions occur and
influence each other in parallel. In everyday
practice, type I reactions such as allergic rhinoconjunctivitis, allergic asthma, urticaria, and
References
13.
14.
References
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
berge P, Williams HC (2004) A revised nomenclature for allergy for global use. Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin
Immunol 113:832 836
Kaplan A (ed) (1986) Allergy. Churchill, Livingstone
Kmmerer H (1928) Allergische Diathese. Bergmann, Munich
Kay B (ed) (1997) Allergy and allergic diseases, 2
volumes. Blackwell, Oxford
Middleton E, Reed CE, Ellis EF (eds) (1998) Allergy. Principles and practice, 5th edn. Mosby, St.
Louis
Mygind N, Dahl R, Pedersen S, Thestrup-Pedersen K (1996) Essential allergy. Blackwell, Oxford
Pirquet C von (1906) Allergie. Mnch Med Wochenschr 30:1457
Ring J, Behrendt H, Vieluf D (eds) (1997) New
trends in allergy IV. Springer, Berlin Heidelberg
New York
Ring J (1985) Erstbeschreibung einer atopischen
Familien-Anamnese im Julisch-Claudischen
Kaiserhaus: Augustus, Claudius, Britannicus.
Hautarzt 36:470 474
Roitt I (1998) Essential immunology, 9th edn.
Blackwell, Oxford
Schadewaldt H (1980 1984) Geschichte der Allergie (4 vols). Dustri, Mnchen-Deisenhofen
Schultze-Werninghaus G, Ring J (2001) 50 Jahre
Deutsche Gesellschaft fr Allergologie und klinische Immunologie (DGAI). Allergo J 10:377 382
Simons E (ed) (1994) Ancestors in allergy. Global
Med Com, New York
Urbach E (1935) Klinik und Therapie der allergischen Krankheiten. Maudrich, Vienna
Vaughan WT, Black JH (1948) Practice of allergy.
Mosby, St. Louis
Wahn U, Seger W, Wahn V (eds) (2004) Allergien
im Kindesalter, 4th edn. Fischer, Stuttgart